Speakers 2013

    • Presentation

    • How to optimize current therapy of G1 patients (chairman) - Monday, January 14th 2013 - 09:20 - 10:30

    • Fibrosis staging: liver biopsy or indirect markers? (chairman) - Tuesday, January 15th 2013 - Interactive Luncheons - Room 6

    View more
  • AGHEMO Alessio

    Italy

      Presentation

    • Genotype 2 - Monday, January 14th 2013 - 11:00

    View more
  • ALAOUI Rhimou

    Morocco

      Presentation

    • Faut-­‐il traiter les immunotolérants et les porteurs inactifs ? (French speaking luncheon) - Tuesday, January 15th 2013 - Interactive Luncheons - Room 8

    View more
  • ASSELAH Tarik

    France

      Presentation

    • State of the art lecture (chairman) - Monday, January 14th 2013 - 08:50 - 09:20

    • Future therapeutic strategies with direct acting antivirals (chairman) - Monday, January 14th 2013 - Interactive luncheons - Room 6

    • IFN-free regimens - Monday, January 14th 2013 - 16:45

    View more
  • BELHADJ BRIK Najet

    Tunisia

      Presentation

    • Comment optimiser le traitement des malades naïfs ? (French speaking luncheon) - Monday, January 14th 2013 - Interactive luncheons - Room 7

    View more
  • BENAZZOUZ Mustapha

    Morocco

      Presentation

    • Comment optimiser le traitement des rechuteurs et non répondeurs (French speaking luncheon) (chairman) - Monday, January 14th 2013 - Interactive luncheons - Room 8

    View more
  • BENHAMOU Yves

    France

      Presentation

    • Treat - Monday, January 14th 2013 -

    View more
  • BERG Thomas

    Germany

      Presentation

    • First line therapy: interferon or analogue? - Tuesday, January 15th 2013 - Interactive Luncheons - Room 3

    • Cirrhosis - Tuesday, January 15th 2013 - 14:45

    View more
  • BONINO Feruccio

    Italy

      Presentation

    • Optimal therapy of HBeAg-negative chronic hepatitis B (chairman) - Tuesday, January 15th 2013 - 11:30 - 12:30

    View more
    • Presentation

    • Cirrhotic patients - Monday, January 14th 2013 - 14:30

    View more
  • BRONOWICKI Jean-Pierre

    France

      Presentation

    • Comment optimiser le traitement des rechuteurs et non répondeurs (French speaking luncheon) - Monday, January 14th 2013 - Interactive luncheons - Room 8

    View more
  • BUTI FERRET Maria

    Spain

      Presentation

    • How to manage relapsers and non-­‐responders to PEG IFN + RBV therapy? - Monday, January 14th 2013 - Interactive luncheons - Room 4

    View more
  • CADRANEL Jean-François

    France

      Presentation

    • Faut-­‐il traiter les immunotolérants et les porteurs inactifs ? (French speaking luncheon) (chairman) - Tuesday, January 15th 2013 - Interactive Luncheons - Room 8

    View more
  • CARDOSO Ana Carolina

    Brazil

      Presentation

    • Fibrosis staging: liver biopsy or indirect markers? - Tuesday, January 15th 2013 - Interactive Luncheons - Room 6

    View more
  • CASTERA Laurent

    France

      Presentation

    • How to manage relapsers and non-­‐responders to PEG IFN + RBV therapy? (chairman) - Monday, January 14th 2013 - Interactive luncheons - Room 4

    View more
  • CHAN Henry

    Hong Kong

      Presentation

    • The control of HBV related liver disease (chairman) - Tuesday, January 15th 2013 - 08:40 - 10:00

    • The clinical applications of HBsAg quantification (chairman) - Tuesday, January 15th 2013 - Interactive Luncheons - Room 5

    View more
  • COLOMBO Massimo

    Italy

      Presentation

    • How to optimize current therapy of G1 patients (chairman) - Monday, January 14th 2013 - 09:20 - 10:30

    • First line therapy: interferon or analogue? (chairman) - Tuesday, January 15th 2013 - Interactive Luncheons - Room 3

    View more
  • CRAXI Antonio

    Italy

      Presentation

    • Predictors of response - Monday, January 14th 2013 - 09:50

    • G1 naive patients: how to optimize treatment? (chairman) - Monday, January 14th 2013 - Interactive luncheons - Room 1

    • The control of HBV related liver disease (chairman) - Tuesday, January 15th 2013 - 08:40 - 10:00

    View more
  • DE LEDINGHEN Victor

    France

      Presentation

    • Fibrosis staging: liver biopsy or indirect markers? - Tuesday, January 15th 2013 - Interactive Luncheons - Room 6

    View more
  • DELFRAISSY Jean-François

    France

      Presentation

    • Research in viral hepatitis: the French ANRS experience - Monday, January 14th 2013 - 08:40

    View more
  • DHUMEAUX Daniel

    France

      Presentation

    • Comment optimiser le traitement des rechuteurs et non répondeurs (French speaking luncheon) (chairman) - Monday, January 14th 2013 - Interactive luncheons - Room 8

    View more
  • DI MARTINO Vincent

    France

      Presentation

    • Triple therapy with telaprevir or boceprevir: management of side effects? - Monday, January 14th 2013 - Interactive luncheons - Room 5

    View more
  • DUSHEIKO Geoffrey

    UK

      Presentation

    • Why do I treat my patient with pegylated IFN? - Tuesday, January 15th 2013 - 10:45

    • Treatment of patients with resistant HBV? (chairman) - Tuesday, January 15th 2013 - Interactive Luncheons - Room 4

    View more
  • El RAY Ahmed

    Egypt

      Presentation

    • G4 patients: how to optimize treatment? - Monday, January 14th 2013 - Interactive luncheons - Room 3

    View more
  • ESMAT Gamal

    Egypt

      Presentation

    • Genotype 4 - Monday, January 14th 2013 - 11:30

    • G4 patients: how to optimize treatment? - Monday, January 14th 2013 - Interactive luncheons - Room 3

    View more
  • ESTEBAN Rafael

    Spain

      Presentation

    • New therapeutic strategies (chairman) - Monday, January 14th 2013 - 16:00 -17:20

    View more
  • FERENCI Peter

    Austria

      Presentation

    • Triple therapy with telaprevir or boceprevir: management of side effects? - Monday, January 14th 2013 - Interactive luncheons - Room 5

    View more
  • FLISIAK Robert

    Poland

      Presentation

    • Future therapeutic strategies with direct acting antivirals - Monday, January 14th 2013 - Interactive luncheons - Room 6

    View more
  • FOSTER Graham

    UK

      Presentation

    • Genotype 3 - Monday, January 14th 2013 - 11:15

    • G4 patients: how to optimize treatment? (chairman) - Monday, January 14th 2013 - Interactive luncheons - Room 3

    • Controversy: F1/F2 patients: treat or wait? (chairman) - Monday, January 14th 2013 - 17:20 - 17:50

    View more
    • Presentation

    • Triple therapy with telaprevir or boceprevir: management of side effects? (chairman) - Monday, January 14th 2013 - Interactive luncheons - Room 5

    • Difficult to treat patients (chairman) - Monday, January 14th 2013 - 14:30 -16:00

    View more
    • Presentation

    • Should immunotolerant and inactive carriers be treated? - Tuesday, January 15th 2013 - Interactive Luncheons - Room 1

    View more
  • HAGAN Liesl

    USA

      Presentation

    • Future therapeutic strategies with direct acting antivirals - Monday, January 14th 2013 - Interactive luncheons - Room 6

    View more
  • HALFON Philippe

    France

      Presentation

    • Resistance to protease inhibitors: is it a real issue? - Monday, January 14th 2013 - Interactive luncheons - Room 2

    • The clinical applications of HBsAg quantification - Tuesday, January 15th 2013 - Interactive Luncheons - Room 5

    View more
  • HEATHCOTE Jenny

    Canada

      Presentation

    • Milestones in therapy of liver diseases - Monday, January 14th 2013 -

    View more
  • HEZODE Christophe

    France

      Presentation

    • Comment optimiser le traitement des malades naïfs ? (French speaking luncheon) (chairman) - Monday, January 14th 2013 - Interactive luncheons - Room 7

    View more
  • ISAKOV Vasily

    Russia

      Presentation

    • G1 naive patients: how to optimize treatment? - Monday, January 14th 2013 - Interactive luncheons - Room 1

    View more
    • Presentation

    • Optimal treatment with telaprevir - Monday, January 14th 2013 - 09:20

    View more
    • Presentation

    • New therapeutic strategies (chairman) - Monday, January 14th 2013 - 16:00 -17:20

    View more
  • JIA Ji Dong

    China

      Presentation

    • Why do I treat my patient with a NUC? - Tuesday, January 15th 2013 - 10:30

    View more
  • KAO Jia-Horng

    Taiwan

      Presentation

    • Optimal therapy of HBeAg-positive chronic hepatitis B (chairman) - Tuesday, January 15th 2013 - 10:30 - 11:30

    View more
  • KRASTEV Zahari

    Bulgaria

      Presentation

    • Interféron ou analogue ? (French speaking luncheon) (chairman) - Tuesday, January 15th 2013 - Interactive Luncheons - Room 7

    View more
  • KUMAR SARIN Shiv

    India

      Presentation

    • Acute hepatitis B and HBV reactivation - Tuesday, January 15th 2013 - 14:30

    View more
  • LADA Olivier

    France

      Presentation

    • Resistance to protease inhibitors: is it a real issue? - Monday, January 14th 2013 - Interactive luncheons - Room 2

    View more
  • LAMPERTICO Pietro

    Italy

      Presentation

    • Why do I treat my patient with pegylated IFN? - Tuesday, January 15th 2013 - 11:45

    • Should immunotolerant and inactive carriers be treated? (chairman) - Tuesday, January 15th 2013 - Interactive Luncheons - Room 1

    View more
  • LAU George

    Hong Kong

      Presentation

    • First line therapy: interferon or analogue? - Tuesday, January 15th 2013 - Interactive Luncheons - Room 3

    View more
  • LEE Sam

    Canada

      Presentation

    • Management of side effects - Monday, January 14th 2013 - 10:05

    • Should immunotolerant and inactive carriers be treated? - Tuesday, January 15th 2013 - Interactive Luncheons - Room 1

    View more
  • LEROY Vincent

    France

      Presentation

    • Treatment of patients with resistant HBV? - Tuesday, January 15th 2013 - Interactive Luncheons - Room 4

    View more
  • LEVRERO Massimo

    Italy

      Presentation

    • Therapy in special populations (chairman) - Tuesday, January 15th 2013 - 14:30 - 16:30

    View more
    • Presentation

    • How to optimize current therapy of non G1 patients (chairman) - Monday, January 14th 2013 - 11:00 - 12:30

    View more
  • LIAW Yun-Fan

    Taiwan

      Presentation

    • Impact of therapy on the outcome of CHB - Tuesday, January 15th 2013 - 08:40

    • Long term impact of treatment on the outcome of the liver disease? (chairman) - Tuesday, January 15th 2013 - Interactive Luncheons - Room 2

    View more
  • LIM Seng Gee

    Singapour

      Presentation

    • Optimal therapy of HBeAg-negative chronic hepatitis B (chairman) - Tuesday, January 15th 2013 - 11:30 - 12:30

    View more
  • MANNS Michael

    Germany

      Presentation

    • Optimal treatment with boceprevir - Monday, January 14th 2013 - 09:35

    View more
  • MARCELLIN Patrick

    France

      Presentation

    • Introduction: Treatment of hepatitis C: the cure - Monday, January 14th 2013 - 08:30

    • State of the art lecture (chairman) - Monday, January 14th 2013 - 12:00 – 12:30

    • Conclusion - Monday, January 14th 2013 - 17:50

    • Introduction: HBV: viral control or clinical cure? - Tuesday, January 15th 2013 - 08:30

    • Conclusion: the next steps - Tuesday, January 15th 2013 - 16:30

    View more
  • MARTINOT-PEIGNOUX Michelle

    France

      Presentation

    • HBsAg quantitation ; clinical applications - Tuesday, January 15th 2013 - 09:10

    • The clinical applications of HBsAg quantification - Tuesday, January 15th 2013 - Interactive Luncheons - Room 5

    View more
  • MATHURIN Philippe

    France

      Presentation

    • Long term impact of treatment on the outcome of the liver disease? - Tuesday, January 15th 2013 - Interactive Luncheons - Room 2

    View more
  • MOUCARI Rami

    United Arab Emirates

      Presentation

    • Interféron ou analogue ? (French speaking luncheon) - Tuesday, January 15th 2013 - Interactive Luncheons - Room 7

    View more
    • Presentation

    • 2nd generation protease inhibitors - Monday, January 14th 2013 - 16:15

    View more
  • OMATA Masao

    Japan

      Presentation

    • Difficult to treat patients (chairman) - Monday, January 14th 2013 - 14:30 -16:00

    View more
  • OULD GOUGAM Rachid

    Algeria

      Presentation

    • Interféron ou analogue ? (French speaking luncheon) - Tuesday, January 15th 2013 - Interactive Luncheons - Room 7

    View more
  • PAIS Raluca

    France

      Presentation

    • G1 naive patients: how to optimize treatment? - Monday, January 14th 2013 - Interactive luncheons - Room 1

    View more
  • PAPATHEODORIDIS Georgios

    Greece

      Presentation

    • Why do I treat my patient with a NUC? - Tuesday, January 15th 2013 - 11:30

    • Treatment of patients with resistant HBV? - Tuesday, January 15th 2013 - Interactive Luncheons - Room 4

    View more
  • PETERSEN Jorg

    Germany

      Presentation

    • The role of combination therapy - Tuesday, January 15th 2013 - 16:00

    View more
  • PIRATVISUTH Teerha

    Thailand

      Presentation

    • Pregnancy - Tuesday, January 15th 2013 - 15:30

    View more
  • POL Stanislas

    France

      Presentation

    • Immuno-suppressed patients - Tuesday, January 15th 2013 - 15:00

    View more
  • POPESCU Adriana

    Romania

      Presentation

    • Faut-­‐il traiter les immunotolérants et les porteurs inactifs ? (French speaking luncheon) - Tuesday, January 15th 2013 - Interactive Luncheons - Room 8

    View more
  • RATZIU Vlad

    France

      Presentation

    • G1 naive patients: how to optimize treatment? (chairman) - Monday, January 14th 2013 - Interactive luncheons - Room 1

    View more
  • RICE Charles

    USA

      Presentation

    • Targets for HCV therapy: clinical applications - Monday, January 14th 2013 -

    View more
    • Presentation

    • Hepatitis delta - Tuesday, January 15th 2013 - 15:45

    View more
  • SAMUEL Didier

    France

      Presentation

    • Transplant patients - Monday, January 14th 2013 - 14:45

    View more
  • SAYEGH Raymond

    Lebanon

      Presentation

    • Comment optimiser le traitement des malades naïfs ? (French speaking luncheon) - Monday, January 14th 2013 - Interactive luncheons - Room 7

    View more
  • SCHIFF Eugene

    USA

      Presentation

    • How to manage relapsers and non-­‐responders to PEG IFN + RBV therapy? (chairman) - Monday, January 14th 2013 - Interactive luncheons - Room 4

    • Optimal therapy of HBeAg-positive chronic hepatitis B (chairman) - Tuesday, January 15th 2013 - 10:30 - 11:30

    View more
  • SCHINAZI Raymond

    USA

      Presentation

    • Resistance to protease inhibitors: is it a real issue? (chairman) - Monday, January 14th 2013 - Interactive luncheons - Room 2

    • Best strategies for global HCV eradication - Monday, January 14th 2013 - 16:00

    View more
  • SERFATY Lawrence

    France

      Presentation

    • How to manage relapsers and non-­‐responders to PEG IFN + RBV therapy? - Monday, January 14th 2013 - Interactive luncheons - Room 4

    View more
  • SHIFFMAN Mitchell

    USA

      Presentation

    • Treat - Monday, January 14th 2013 -

    View more
  • SULKOWSKI Mark

    USA

      Presentation

    • HIV co-infected patients - Monday, January 14th 2013 - 15:00

    View more
  • THURSZ Mark

    UK

      Presentation

    • How to optimize current therapy of non G1 patients (chairman) - Monday, January 14th 2013 - 11:00 - 12:30

    View more
  • TRAN Albert

    France

      Presentation

    • Comment optimiser le traitement des rechuteurs et non répondeurs (French speaking luncheon) - Monday, January 14th 2013 - Interactive luncheons - Room 8

    View more
  • TREPO Christian

    France

      Presentation

    • Faut-­‐il traiter les immunotolérants et les porteurs inactifs ? (French speaking luncheon) (chairman) - Tuesday, January 15th 2013 - Interactive Luncheons - Room 8

    View more
  • VOICULESCU Mihai

    Romania

      Presentation

    • Comment optimiser le traitement des malades naïfs ? (French speaking luncheon) (chairman) - Monday, January 14th 2013 - Interactive luncheons - Room 7

    View more
  • YAZDANPANAH Yazdan

    France

      Presentation

    • Long term impact of treatment on the outcome of the liver disease? - Tuesday, January 15th 2013 - Interactive Luncheons - Room 2

    View more
  • ZARSKI Jean-Pierre

    France

      Presentation

    • Interféron ou analogue ? (French speaking luncheon) (chairman) - Tuesday, January 15th 2013 - Interactive Luncheons - Room 7

    • Therapy in special populations (chairman) - Tuesday, January 15th 2013 - 14:30 - 16:30

    View more
  • ZEUZEM Stefan

    Germany

      Presentation

    • Polymerase inhibitors - Monday, January 14th 2013 - 16:30

    View more
  • ZOULIM Fabien

    France

      Presentation

    • Optimal management of patients with resistance - Tuesday, January 15th 2013 - 08:55

    View more